SYNGENE

Market Cap: ₹27,040 Cr P/E Ratio (TTM): 54–57× P/B Ratio: 5.7× Dividend Yield: 0.18–0.19% Valuation is high vs. broader benchmarks (PE 55x vs. Nifty 20x), reflecting CDMO premium—but earnings growth needs to justify it.